|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.1 USD | -12.00% |
|
-3.51% | -38.20% |
| May. 10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
| May. 10 | Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q1 Revenue $3.7M, vs. Street Est of $9.2M | MT |
Protalix BioTherapeutics, Inc. announced that it has chosen Mr. Shlomo Yanai as Chairman of the company's Board of Directors, effective on July 24, 2014. Mr. Zeev Bronfeld, the interim Chairman of the Board, will remain a member of the Board of Directors. Currently, Mr. Yanai is a member of the Board of Governors of The Technion.
Mr. Yanai is also the Chairman of the Board of Directors of Cambrex Corporation, and is on the board of Lumenis Ltd.
| 1st Jan change | Capi. | |
|---|---|---|
| -38.20% | 80.65M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
PROTALIX BIOTHERAPEUTICS, INC. 
